Palmoplantar pustulosis https://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis bụ dermatosis pustular (pustular dermatosis) (ya bụ, pustulosis ma ọ bụ pustular psoriasis) nke etinyere na ọbụ aka na ọbụ ụkwụ naanị, nke e ji akụkọ ihe mere eme site na pustules intraepidermal jupụtara na neutrophils. Ojiji nke sistemu retinoids naanị yana photochemotherapy iji meziwanye akara palmoplantar pustulosis.

○ Ọgwụgwọ
Oral acitretin dị irè maka ụdị psoriasis a.
#Acitretin
Ozi ndị ọzọ ― Igbo
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis bụ ụdị psoriasis nke na-emetụta akpụkpọ ahụ n'ọbụ aka na ọbụ ụkwụ gị. Ọ na-apụta dị ka akpụkpọ anụ nke nwere nkụ, ọnya, ma ọ bụ ngwakọta nke ụdị abụọ ahụ.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).